(Q37814406)

23 August 2017

1 reference

title

Neurofibromatosis type 1 in childhood (English)

1 reference

23 August 2017

Listernick R

1

1 reference

23 August 2017

Charrow J

series ordinal

2

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 June 1990

1 reference

The Journal of Pediatrics

23 August 2017

published in

1 reference

23 August 2017

volume

116

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

845-853

1 reference

Further diagnostic thoughts about the Elephant Man.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Diagnostic importance of café-au-lait spot in neurofibromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

AXILLARY FRECKLING AS A DIAGNOSTIC AID IN NEUROFIBROMATOSIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Melanin macroglobules as a cellular marker of neurofibromatosis: a quantitative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Pathology of nerve sheath tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

1977 Edward B. D. Neuhauser lecture: neurofibromatosis in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Optic gliomas in children with neurofibromatosis type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Neurofibromatosis and malignant childhood cancers: a survey in Italy, 1970-83

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Childhood neurofibromatosis: risk factors for malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Treatment of children with neurogenic sarcoma. Experience at the Children's Hospital of Philadelphia, 1958-1984

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Neurofibromatosis and childhood leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Association of juvenile xanthogranuloma with juvenile myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

The relationship between nephroblastoma and neurofibromatosis (Von Recklinghausen's disease)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

The brain in multiple neurofibromatosis (von Recklinghausen's disease): a suggested neuropathological basis for the associated mental defect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

A distinctive facial appearance in neurofibromatosis von Recklinghausen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Noonan phenotype associated with neurofibromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

The neurofibromatosis-Noonan syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

The neurofibromatosis-Noonan syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Evidence that the "neurofibromatosis-Noonan syndrome" is a variant of von Recklinghausen neurofibromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Investigations on the neural crest. Methodological aspects and recent advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

The biology and mechanism of action of nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Schwann-like cells cultured from human dermal neurofibromas. Immunohistological identification and response to Schwann cell mitogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Increased nerve-growth-stimulating activity in disseminated neurofibromatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Letter: Nerve-growth factor in disseminated neurofibromatosis;

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Models for inherited susceptibility to cancer in the nervous system: a molecular-genetic approach to neurofibromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Serum neuronal growth factor levels in von Recklinghausen's neurofibromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Glial growth factor-like activity in Schwann cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Pathophysiology of neurofibromatosis. IV. Dermatologic insights into heterogeneity and pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

The significance of MRI abnormalities in children with neurofibromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Neuroaudiologic abnormalities in patients with type 1 neurofibromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Controversy in the management of optic nerve glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Chiasmatic optic glioma treated with chemotherapy. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Cisplatin in the treatment of recurrent childhood primary brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Neurofibromatosis 2 (bilateral acoustic neurofibromatosis).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

Segmental neurofibromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980639-0

10.1016/S0022-3476(05)80639-0

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference